International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

Crunelle, Cleo L.; van den Brink, Wim; Moggi, Franz; Konstenius, Maija; Franck, Johan; Levin, Frances R.; van de Glind, Geurt; Demetrovics, Zsolt; Coetzee, Corné; Luderer, Mathias; Schellekens, Arnt; Matthys, Frieda (2018). International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder. European addiction research, 24(1), pp. 43-51. Karger 10.1159/000487767

[img] Text
Crunelle et al. EAR 2018.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (204kB) | Request a copy

Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended. Long-acting methylphenidate, extended-release amphetamines, and atomoxetine with up-titration to higher dosages may be considered in patients unresponsive to standard doses. This paper includes evidence- and consensus-based recommendations developed to provide guidance in the screening, diagnosis and treatment of patients with ADHD-SUD comorbidity.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Translational Research Center
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Healthcare Research

UniBE Contributor:

Moggi, Franz

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1022-6877

Publisher:

Karger

Language:

English

Submitter:

Franz Moggi

Date Deposited:

19 Apr 2018 17:01

Last Modified:

23 Oct 2019 08:28

Publisher DOI:

10.1159/000487767

PubMed ID:

29510390

Uncontrolled Keywords:

Attention deficit/hyperactivity disorder · Substance use disorders · Diagnosis · Treatment · Consensus

BORIS DOI:

10.7892/boris.113238

URI:

https://boris.unibe.ch/id/eprint/113238

Actions (login required)

Edit item Edit item
Provide Feedback